CONCENTRATION : 5mg bottle of  TIRZEPATIDE Research Chemical 

• Must purchase BACTERIOSTATIC WATER to mix.

Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss. Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent.

Uses and Benefits of Tirzepatide:

1. Treatment of type 2 diabetes mellitus: Tirzepatide is indicated for the management of type 2 diabetes mellitus, a chronic condition characterized by insulin resistance and relative insulin deficiency.

2.  Improved glycemic control: Tirzepatide helps regulate blood sugar levels by stimulating insulin release and inhibiting glucagon secretion, leading to better glycemic control and reduced fluctuations in blood glucose levels. 
   
   
3. Weight loss: Tirzepatide has been shown to promote weight loss in patients with type 2 diabetes, which can be beneficial for overall health and may also improve insulin sensitivity.      
   
   
4. Potential reduction in cardiovascular risk: Some studies suggest that tirzepatide may have cardiovascular benefits beyond glycemic control, potentially reducing the risk of cardiovascular events such as heart attacks and strokes.                                                                         
   
   
5. Combined action as a dual GIP and GLP-1 receptor agonist: Tirzepatide acts on both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, harnessing the benefits of both incretin hormones to improve glucose metabolism.                                                                  
   
   
6. Stimulation of insulin release: Tirzepatide stimulates the release of insulin from pancreatic beta cells in response to elevated blood sugar levels, helping to lower blood glucose levels after meals.                                                                   
   
   
7. Inhibition of glucagon secretion: Tirzepatide inhibits the secretion of glucagon, a hormone that raises blood sugar levels by promoting the release of glucose from the liver, thereby reducing excessive glucose production.                   
   
   
8. Once-weekly dosing regimen for convenience: Tirzepatide is administered once weekly, offering a convenient dosing regimen that may improve treatment adherence compared to medications requiring daily dosing.

TERMS: All items offered by CONQUER RESEARCH are explicitly designated for research and laboratory purposes exclusively. These products are not intended, formulated, or approved for human consumption, medical, veterinary, or household applications. It is strictly prohibited to utilize any items acquired from CONQUER RESEARCH for purposes other than research and laboratory use. This prohibition encompasses, but is not limited to, any form of consumption, medical treatment, veterinary use, or household application. CONQUER RESEARCH upholds a no-sell list of individuals and entities discovered violating our intended use policy. Those found using our products improperly will be included in this list, preventing future purchases from CONQUER RESEARCH.